BIAFW

bioAffinity Technologies (BIAFW)

bioAffinity Technologies Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:BIAFW

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/06/15	09:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/06/15	09:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/06/15	09:45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/06/12	21:00	Business Wire	bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/06/06	05:30	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/06/06	05:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/05/23	05:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/05/23	05:00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/05/15	23:53	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/05/15	22:15	Business Wire	bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/05/02	21:00	Business Wire	bioAffinity Technologies News Update	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/04/24	21:00	Business Wire	bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/04/09	21:00	Business Wire	bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/04/01	22:49	Business Wire	bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/03/09	02:45	Business Wire	bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/03/06	23:46	Business Wire	bioAffinity Technologies Announces Pricing of $2.5 Million Registered Direct Offering and Concurrent Private Placement	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/02/21	22:00	Business Wire	bioAffinity Technologies News Update	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/01/30	22:00	Business Wire	bioAffinity Technologies In The News	NASDAQ:BIAFW	bioAffinity Technologies Inc
2024/01/08	22:00	Business Wire	bioAffinity Technologies In the News	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/12/05	22:00	Business Wire	bioAffinity Technologies Appoints Jamie Platt, Ph.D., to its Board of Directors	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/11/30	22:00	Business Wire	CMS Posts Final Payment Determination for bioAffinity Technologies’ CyPath® Lung Effective January 2024	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/11/28	22:00	Business Wire	bioAffinity Technologies VP David Elzi, Ph.D., Named to American Society for Cell Biology Post	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/11/15	06:01	Business Wire	bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/11/06	22:00	Business Wire	bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/10/10	21:00	Business Wire	bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/09/07	21:00	Business Wire	bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/08/15	06:03	Business Wire	bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/07/12	21:00	Business Wire	AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/06/15	21:00	Business Wire	bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium	NASDAQ:BIAFW	bioAffinity Technologies Inc
2023/05/22	21:00	Business Wire	bioAffinity Technologies Presents Research Findings at CYTO 2023	NASDAQ:BIAFW	bioAffinity Technologies Inc